Analysis of Fluoroquinolone resistance in clinical isolates of Mycobacterium tuberculosis from India

Sulochana, S and Narayanan, S and Paramasivan, C N and Suganthi, C and Narayanan, P R (2007) Analysis of Fluoroquinolone resistance in clinical isolates of Mycobacterium tuberculosis from India. Journal of Chemotherapy, 19 (2). pp. 166-171. ISSN Print: 1120-009X; Online: 1973-9478

[thumbnail of 200747.pdf] PDF
200747.pdf - Published Version
Restricted to Registered users only

Download (483kB) | Request a copy


Clinical isolates of Mycobacterium tuberculosis (47 ofloxacin-susceptible and 71 ofloxacin-resistant) strains obtained from individual patients from various parts of India were analyzed for gyr A mutation in quinolone resistant determining region (QRDR). Most of the mutations were seen clustered in the codons 90, 94 and 95, which is a hot spot region of QRDR. The types of mutations were correlated with the in vitro susceptibility pattern of the strains to ofloxacin. The mutations: A90V was found coded for low-level resistance (MIC < 16 m g/ml), D94A and D94V were coded for moderate level resistance (MIC 32-64 m g/ml) and S91P, D94G and D94N were coded for high level resistance (MIC >64 m g/ml) to ofloxacin. The resistance to fluoroquinolones was observed predominantly due to gyr A mutations. There were 2 highly resistant strains that did not show any mutations for gyr A, were further analyzed for gyr B mutations and were found negative for any mutations. However, there were two novel mutations, namely R68G and L109V, which were found in sensitive strain that did not code for any change in the susceptibility pattern and require further investigation.

Item Type: Article
Uncontrolled Keywords: Mycobacterium tuberculosis , gyr A mutations, fluoroquinolones, M. tuberculosis
Subjects: Tuberculosis > Laboratory Research > Bacteriological
Divisions: Basic Science Research > Bacteriology
Depositing User: Dr. Rathinasabapati R
Date Deposited: 10 Jan 2014 07:57
Last Modified: 30 Mar 2021 05:32

Actions (login required)

View Item View Item